These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20563581)

  • 1. Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates.
    Baxter PA; Thompson PA; McGuffey LM; Gibson BW; Dauser RC; Nuchtern JG; Shi C; Inloes R; Choy G; Redkar S; Blaney SM
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):809-12. PubMed ID: 20563581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates.
    Kim A; McCully C; Cruz R; Cole DE; Fox E; Balis FM; Widemann BC
    Invest New Drugs; 2012 Apr; 30(2):524-8. PubMed ID: 21072558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
    Stapleton SL; Thompson PA; Ou CN; Berg SL; McGuffey L; Gibson B; Blaney SM
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):647-52. PubMed ID: 17541590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.
    Neville K; Parise RA; Thompson P; Aleksic A; Egorin MJ; Balis FM; McGuffey L; McCully C; Berg SL; Blaney SM
    Clin Cancer Res; 2004 Apr; 10(7):2525-9. PubMed ID: 15073132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non-human primate model.
    Cole DE; Lester-McCully CM; Widemann BC; Warren KE
    Cancer Chemother Pharmacol; 2015 May; 75(5):923-8. PubMed ID: 25740692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.
    Marcus L; Murphy R; Fox E; McCully C; Cruz R; Warren KE; Meyer T; McNiff E; Balis FM; Widemann BC
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):247-52. PubMed ID: 21706317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and cerebrospinal fluid penetration of CI-994 (N-acetyldinaline) in the nonhuman primate.
    Riva L; Blaney SM; Dauser R; Nuchtern JG; Durfee J; McGuffey L; Berg SL
    Clin Cancer Res; 2000 Mar; 6(3):994-7. PubMed ID: 10741726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid pharmacokinetics of thalidomide and lenalidomide in nonhuman primates.
    Muscal JA; Sun Y; Nuchtern JG; Dauser RC; McGuffey LH; Gibson BW; Berg SL
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):943-7. PubMed ID: 22109830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates.
    Berg SL; Stone J; Xiao JJ; Chan KK; Nuchtern J; Dauser R; McGuffey L; Thompson P; Blaney SM
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):85-8. PubMed ID: 15042312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates.
    Renbarger J; Aleksic A; McGuffey L; Dauser R; Berg S; Blaney S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):39-42. PubMed ID: 14551735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
    Stapleton SL; Reid JM; Thompson PA; Ames MM; McGovern RM; McGuffey L; Nuchtern J; Dauser R; Blaney SM
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):461-6. PubMed ID: 16855840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.
    Jacobs SS; Fox E; Dennie C; Morgan LB; McCully CL; Balis FM
    Clin Cancer Res; 2005 Feb; 11(4):1669-74. PubMed ID: 15746072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates.
    Muscal JA; Thompson PA; Giranda VL; Dayton BD; Bauch J; Horton T; McGuffey L; Nuchtern JG; Dauser RC; Gibson BW; Blaney SM; Su JM
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):419-25. PubMed ID: 19526240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates.
    Warren KE; McCully C; Dvinge H; Tjørnelund J; Sehested M; Lichenstein HS; Balis FM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):433-7. PubMed ID: 17960383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite (OSI-420) after intravenous administration of erlotinib in non-human primates.
    Meany HJ; Fox E; McCully C; Tucker C; Balis FM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):387-92. PubMed ID: 17932674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.
    Fox E; Murphy RF; McCully CL; Adamson PC
    Cancer Chemother Pharmacol; 2001; 47(1):41-4. PubMed ID: 11221960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model.
    League-Pascual JC; Lester-McCully CM; Shandilya S; Ronner L; Rodgers L; Cruz R; Peer CJ; Figg WD; Warren KE
    J Neurooncol; 2017 May; 132(3):401-407. PubMed ID: 28290002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid penetration of the colony-stimulating factor-1 receptor (CSF-1R) inhibitor, pexidartinib.
    Shankarappa PS; Peer CJ; Odabas A; McCully CL; Garcia RC; Figg WD; Warren KE
    Cancer Chemother Pharmacol; 2020 May; 85(5):1003-1007. PubMed ID: 32306101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.
    Berg SL; Brueckner C; Nuchtern JG; Dauser R; McGuffey L; Blaney SM
    Cancer Chemother Pharmacol; 2007 May; 59(6):743-7. PubMed ID: 16953392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates.
    Cho SY; Fox E; McCully C; Bauch J; Marsh K; Balis FM
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):563-7. PubMed ID: 17187251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.